Platelet factor 3 (PF3) was assayed by Russell's viper venom (RVV) in
three plasma fractions, platelet-rich plasma (PRP), platelet poor plas
ma (PPP), and 0.1 mu m particle-filtered plasma (PFP), in 42 healthy c
ontrols, 34 patients with recent cerebrovascular accidents (CVA) and 2
8 with recent ischemic events from coronary artery disease (CAD). Plat
elet microparticles (PMP) were assayed in PPP by flow cytometry. Relat
ive to controls, the RVV clotting times were shortened in all three pl
asma fractions in both patient groups, p < 0.001. PMP were also elevat
ed in both patient groups, p < 0.001. Linear regression analysis showe
d that the RVV times of PPP are inversely correlated with PMP, p < 0.0
05, in patient groups but not in controls. There was no correlation of
RVV time with PT, APTT or FIB. After converting RVV times to units of
PF3 activity, it could be shown that only about 1/4 of the total PF3
activity was contributed by platelets. The major contribution to the P
F3 activity in controls was from microparticles < 0.1 mu m but in pati
ents was due mainly to microparticles > 0.1 mu m The RVV time was supe
rior to routine coagulation tests in discriminating thrombotic patient
s from healthy controls.